- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06737211
Optimizing Postoperative Nutrition in Colorectal Surgery (OPTI-NUTRICS)
January 3, 2026 updated by: Maximos Frountzas, National and Kapodistrian University of Athens
Optimizing Postoperative Nutrition in Colorectal Surgery: a Prospective Randomized Clinical Trial.
Major surgical operations of the gastrointestinal tract, such as colorectal resections due to several diseases, lead to significant burden on the human body, which is expressed during the first postoperative hours with an intense inflammatory reaction and consumption of a large amount of energy, increasing nutritional requirements of the patients.
Therefore, specific protocols have been implemented for the early initiation of oral feeding in patients undergoing colorectal resections.
However, it is not feasible for every patient to meet them due to several reasons, such as old age and associated pathophysiological changes, use of opioid drugs for the management of postoperative pain, which is associated with postoperative ileus or nausea, as well as open resection which lead to gastrointestinal impairment during the first postoperative days.
The energy deficit that occurs during the early postoperative period, which appears to be associated with adverse clinical outcomes, can be counterbalanced by the administration of parenteral nutrition.
However, the conventional way of administration through central venous lines is associated with significant complications.
For this reason, administration of parenteral nutrition through a peripheral venous catheter could be used alternatively, which avoids morbidity and has been also effective in maintaining the patients' energy balance, even during the first postoperative hours.
Therefore, the main purpose of the present study is to investigate the efficacy of the administration of peripheral parenteral nutrition on the postoperative outcomes of patients undergoing colorectal resections.
Moreover, the correlation of the administration of peripheral parenteral nutrition with the reaction to post-operative stress and with the nutritional status of the patients post-operatively, which are determining factors for the clinical course of these patients, will be investigated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Athens, Greece
- Hippocration General Hospital of Athens
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Colorectal resection surgery
- Open or laparoscopic procedures
- Anastomosis, end-stoma or defunctioning stoma formation after colorectal resection
- Elective or emergent procedures
- Diagnosis of colorectal cancer, inflammatory bowel disease, diverticular disease and bowel ischemia
- Small bowel resection combined with colorectal resection
- Age > 18 years old
- Informed consent
Exclusion Criteria:
- Small bowel resection without colorectal resection
- End-stoma or defunctioning stoma formation without colorectal resection
- Preoperative parenteral nutrition administration
- Administration of parenteral nutrition after the 4th postoperative day
- Peripheral parenteral nutrition initiation after the 1st postoperative day
- Contraindication for peripheral parenteral nutrition administration
- Age < 18 years old
- No informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
2000 mL of peripheral parenteral nutrition with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a peripheral venous catheter with a rhythm of 80cc/h from the time they will leave the operation room and will be transferred to the ward or the critical care unit (CCU) until the 5th postoperative day
|
2000 mL of peripheral parenteral nutrition with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a peripheral venous catheter with a rhythm of 80cc/h from the time they will leave the operation room and will be transferred to the ward or the critical care unit (CCU) until the 5th postoperative day
|
|
No Intervention: Control
1000 mL of 10% glucose saline with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a central or peripheral venous catheter with a rhythm of 80cc/h until the 5th postoperative day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Surgical Stress and Short-term Nutritional Status
Time Frame: 5 postoperative days
|
Serum nutritional markers and acute phase proteins indicating postoperative surgical stress response.
|
5 postoperative days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Morbidity
Time Frame: 90 postoperative days
|
Complications after surgery and their classification according to Calvin-Dindo score.
|
90 postoperative days
|
|
Nasogastric tube removal
Time Frame: 30 postoperative days
|
Postoperative day of nasogastric tube removal
|
30 postoperative days
|
|
Feeding start
Time Frame: 30 postoperative days
|
Postoperative day of feeding start
|
30 postoperative days
|
|
Early mobilization
Time Frame: 30 postoperative days
|
Postoperative day of mobilization
|
30 postoperative days
|
|
Opioid sparing analgesia
Time Frame: 30 postoperative days
|
Utilization of epidural sparing catheter
|
30 postoperative days
|
|
Peripheral Parenteral Nutrition - associated complications
Time Frame: 30 postoperative days
|
Thrombophlebitis, hyperglycemia, re-feeding syndrome
|
30 postoperative days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Shin CH, Long DR, McLean D, Grabitz SD, Ladha K, Timm FP, Thevathasan T, Pieretti A, Ferrone C, Hoeft A, Scheeren TWL, Thompson BT, Kurth T, Eikermann M. Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study. Ann Surg. 2018 Jun;267(6):1084-1092. doi: 10.1097/SLA.0000000000002220.
- Gillis C, Carli F. Promoting Perioperative Metabolic and Nutritional Care. Anesthesiology. 2015 Dec;123(6):1455-72. doi: 10.1097/ALN.0000000000000795.
- Studer P, Raber G, Ott D, Candinas D, Schnuriger B. Risk factors for fatal outcome in surgical patients with postoperative aspiration pneumonia. Int J Surg. 2016 Mar;27:21-25. doi: 10.1016/j.ijsu.2016.01.043. Epub 2016 Jan 20.
- Herbert G, Perry R, Andersen HK, Atkinson C, Penfold C, Lewis SJ, Ness AR, Thomas S. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications. Cochrane Database Syst Rev. 2019 Jul 22;7(7):CD004080. doi: 10.1002/14651858.CD004080.pub4.
- Cardinale F, Chinellato I, Caimmi S, Peroni DG, Franceschini F, Miraglia Del Giudice M, Bernardini R. Perioperative period: immunological modifications. Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3 Suppl):S3-12. doi: 10.1177/03946320110240s302.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2024
Primary Completion (Actual)
August 20, 2025
Study Completion (Actual)
November 20, 2025
Study Registration Dates
First Submitted
December 7, 2024
First Submitted That Met QC Criteria
December 11, 2024
First Posted (Actual)
December 17, 2024
Study Record Updates
Last Update Posted (Actual)
January 6, 2026
Last Update Submitted That Met QC Criteria
January 3, 2026
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nutrition Disorders
- Neoplasms by Site
- Neoplasms
- Signs and Symptoms, Digestive
- Intestinal Diseases
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colonic Diseases
- Gastroenteritis
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Malnutrition
- Colorectal Neoplasms
- Inflammatory Bowel Diseases
- Hyperphagia
Other Study ID Numbers
- OPTI-NUTRICS study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Bowel Diseases
-
Cook Children's Health Care SystemNot yet recruitingIBD | IBD - Inflammatory Bowel Disease | IBD (Inflammatory Bowel Disease)United States
-
Ningbo Medical Center Lihuili HospitalRecruitingInflammatory Bowel Disease (IBD)China
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingIBD - Inflammatory Bowel DiseaseItaly
-
Chang Kyun LeeChonnam National University Hospital; Kyungpook National University Hospital; Chung-Ang University Hosptial, Chung-Ang University College of Medicine and other collaboratorsRecruitingInflammatory Bowel Disease (IBD)Korea, Republic of
-
Xijing HospitalNot yet recruitingInflammatory Bowel Diseases (IBD)China
-
Assiut UniversityNot yet recruitingInflammatory Bowel Disease (IBD)
-
University of British ColumbiaCompletedInflammatory Bowel Disease 11Canada
-
University of ChicagoTerminatedInflammatory Bowel Disease (IBD)United States
-
University of Texas Southwestern Medical CenterEnrolling by invitationInflammatory Bowel Disease | Inflammatory Bowel Disease (IBD)United States
-
University Hospital, GrenobleInstitute for Advanced Biosciences (IAB), GrenobleNot yet recruitingInflammatory Bowel Disease (IBD)France
Clinical Trials on Peripheral Parenteral Nutrition
-
Soonchunhyang University HospitalJW PharmaceuticalRecruiting
-
Hospital Pediátrico de SinaloaRecruitingCholestasis in NewbornMexico
-
Antonio Arroyo SebastianUnknownColon Cancer | Parenteral Nutrition | Fast-trackSpain
-
Instituto do Cancer do Estado de São PauloUnknownCancer | Abdominal Surgery | Parenteral NutritionBrazil
-
Göteborg UniversityCompleted
-
Karaganda Medical UniversityCompletedPostoperative | Nutritional Support | Hepato-Biliary NeoplasmKazakhstan
-
University of ManchesterShire International GmbHCompleted
-
London North West Healthcare NHS TrustSt Mark's Hospital FoundationUnknownEnterocutaneous FistulaeUnited Kingdom
-
University Hospital, LilleMinistry of Health, FranceTerminatedGastrointestinal Fistula | Enteral Nutritional SupportFrance
-
Dong ZhangRecruitingCritical Illness | Organ Dysfunction | Enteral Nutrition Intolerance | Inadequate Nutritional IntakeChina